On 2025-05-14, Benitec Biopharma Limited (BNTC) announced earnings per share of $-0.24 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.36.
The next expected annoucement date for quarterly earnings is 2025-09-25, with an average estimated earnings per share of $-0.23 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.36 | $-0.24 |
| 2025-02-14 | 2024-12-31 | $-1.00 | $-0.36 |
| 2024-11-14 | 2024-09-30 | $-0.61 | $-0.48 |
| 2024-05-13 | 2024-03-31 | -- | $-1.64 |
| 2024-02-13 | 2023-12-31 | -- | $-2.64 |
| 2023-11-13 | 2023-09-30 | -- | $-2.76 |
| 2023-05-15 | 2023-03-31 | -- | $-2.72 |
| 2023-02-13 | 2022-12-31 | -- | $-3.40 |
| 2022-11-10 | 2022-09-30 | $-2.04 | $-7.99 |
| 2022-09-02 | 2022-06-30 | $-4.76 | $-10.54 |
| 2022-05-16 | 2022-03-31 | $-7.48 | $-6.80 |
| 2022-02-14 | 2021-12-31 | -- | $-10.03 |
| 2021-11-15 | 2021-09-30 | -- | $-10.54 |
| 2021-09-20 | 2021-06-30 | -- | $-5.10 |
| 2021-05-12 | 2021-03-31 | -- | $-13.95 |
| 2021-02-09 | 2020-12-31 | -- | $-2572.45 |
| 2020-11-13 | 2020-09-30 | -- | $-41.67 |
| 2018-09-04 | 2018-06-30 | -- | $-51.02 |
| 2018-05-31 | 2018-03-31 | -- | $-56.12 |
| 2018-02-22 | 2017-12-31 | -- | $-56.12 |
| 2017-11-29 | 2017-09-30 | -- | $-56.12 |
| 2017-08-29 | 2017-06-30 | -- | $-51.02 |
| 2017-05-30 | 2017-03-31 | -- | $-2.55 |
| 2017-02-23 | 2016-12-31 | -- | $-91.83 |
| 2016-11-22 | 2016-09-30 | -- | $20.41 |